Abbott Laboratories stock holds firm after Q2 beat
Published on 08/21/2026 at 12:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Abbott Laboratories (US0028241000) held firm after a July 16, 2026 earnings update that showed $1.31 per share, above the $1.28 consensus, on revenue of $12.59 billion. The company also lifted guidance for Q3 2026 to $1.38-$1.46 per share and for FY 2026 to $5.45-$5.60 per share.
Guidance still leads
The latest report also pointed to 13.0% year-over-year revenue growth, with net margin at 11.65% and return on equity at 17.69%. That mix matters for investors because it pairs growth with profit, not just top-line expansion.
On August 21, 2026, Abbott stock opened at $114.16, with a market capitalization of $197.54 billion, a 52-week range of $81.97 to $137.49 and a 200-day moving average of $99.93. The shares were also trading above the consensus target of $118.67 from recent analyst coverage, while the average rating stood at Moderate Buy.
Analysts stay constructive
Recent coverage has kept the stock in a favorable light, with one upgrade to Outperform and several price targets clustered above the current quote. The spread between the $114.16 opening price and the $118.67 average target leaves only a modest gap in market expectations.
That setup gives Abbott a rare combination of a fresh earnings beat, raised outlook and a stock price that already reflects part of the optimism. The next test is whether the updated guidance turns into another quarter of margin stability.
Medical devices matter
Abbott's medical devices arm remains a core growth engine, especially in continuous glucose monitoring and cardiovascular products. The recent earnings print showed the broader portfolio still translating that demand into double-digit revenue growth.
Abbott stock at a glance
Abbott stock traded at $114.16 on August 21, 2026, against a market cap of $197.54 billion and a 52-week range of $81.97 to $137.49. The earnings update on July 16, 2026, remains the central catalyst behind the current setup.
Fact box
Company: Abbott Laboratories
ISIN: US0028241000
Ticker: ABT
Exchange: NYSE
Sector / Industry: Healthcare / Medical Devices
Market cap: $197.54 billion (as of August 21, 2026)
Price (as of August 21, 2026): $114.16 USD
